Literature DB >> 34560105

Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axis.

Vadim Pivniouk1, Joao A Gimenes-Junior2, Peace Ezeh2, Ashley Michael2, Oksana Pivniouk2, Seongmin Hahn2, Sydney R VanLinden2, Sean P Malone2, Amir Abidov3, Dayna Anderson2, Justyna Gozdz2, Avery DeVries4, Fernando D Martinez4, Christian Pasquali5, Donata Vercelli6.   

Abstract

BACKGROUND: Microbial interventions against allergic asthma have robust epidemiologic underpinnings and the potential to recalibrate disease-inducing immune responses. Oral administration of OM-85, a standardized lysate of human airways bacteria, is widely used empirically to prevent respiratory infections and a clinical trial is testing its ability to prevent asthma in high-risk children. We previously showed that intranasal administration of microbial products from farm environments abrogates experimental allergic asthma.
OBJECTIVES: We sought to investigate whether direct administration of OM-85 to the airway compartment protects against experimental allergic asthma; and to identify protective cellular and molecular mechanisms activated through this natural route.
METHODS: Different strains of mice sensitized and challenged with ovalbumin or Alternaria received OM-85 intranasally, and cardinal cellular and molecular asthma phenotypes were measured. Airway transfer experiments assessed whether OM-85-treated dendritic cells protect allergen-sensitized, OM-85-naive mice against asthma.
RESULTS: Airway OM-85 administration suppressed allergic asthma in all models acting on multiple innate and adaptive immune targets: the airway epithelium/IL-33/ILC2 axis, lung allergen-induced type 2 responses, and dendritic cells whose Myd88/Trif-dependent tolerogenic reprogramming was sufficient to transfer OM-85-induced asthma protection.
CONCLUSIONS: We provide the first demonstration that administering a standardized bacterial lysate to the airway compartment protects from experimental allergic asthma by engaging multiple immune pathways. Because protection required a cumulative dose 27- to 46-fold lower than the one reportedly active through the oral route, the efficacy of intranasal OM-85 administration may reflect its direct access to the airway mucosal networks controlling the initiation and development of allergic asthma.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial lysate; OM-85; adaptive immunity; airway compartment; allergic inflammation; asthma; innate immunity; intranasal route; microbial interventions

Mesh:

Substances:

Year:  2021        PMID: 34560105      PMCID: PMC8901455          DOI: 10.1016/j.jaci.2021.09.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  48 in total

1.  Early infancy microbial and metabolic alterations affect risk of childhood asthma.

Authors:  Marie-Claire Arrieta; Leah T Stiemsma; Pedro A Dimitriu; Lisa Thorson; Shannon Russell; Sophie Yurist-Doutsch; Boris Kuzeljevic; Matthew J Gold; Heidi M Britton; Diana L Lefebvre; Padmaja Subbarao; Piush Mandhane; Allan Becker; Kelly M McNagny; Malcolm R Sears; Tobias Kollmann; William W Mohn; Stuart E Turvey; B Brett Finlay
Journal:  Sci Transl Med       Date:  2015-09-30       Impact factor: 17.956

Review 2.  IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy.

Authors:  Corinne Cayrol; Jean-Philippe Girard
Journal:  Curr Opin Immunol       Date:  2014-09-29       Impact factor: 7.486

3.  Transplacental immune modulation with a bacterial-derived agent protects against allergic airway inflammation.

Authors:  Kyle T Mincham; Naomi M Scott; Jean-Francois Lauzon-Joset; Jonatan Leffler; Alexander N Larcombe; Philip A Stumbles; Sarah A Robertson; Christian Pasquali; Patrick G Holt; Deborah H Strickland
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

Review 4.  Childhood Asthma Inception and Progression: Role of Microbial Exposures, Susceptibility to Viruses and Early Allergic Sensitization.

Authors:  Fernando D Martinez
Journal:  Immunol Allergy Clin North Am       Date:  2019-05       Impact factor: 3.479

5.  Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.

Authors:  Christina A Christianson; Nicholas P Goplen; Iram Zafar; Chaoyu Irvin; James T Good; Donald R Rollins; Balachandra Gorentla; Weimin Liu; Magdalena M Gorska; HongWei Chu; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2015-01-21       Impact factor: 10.793

6.  Environmental exposure to endotoxin and its relation to asthma in school-age children.

Authors:  Charlotte Braun-Fahrländer; Josef Riedler; Udo Herz; Waltraud Eder; Marco Waser; Leticia Grize; Soyoun Maisch; David Carr; Florian Gerlach; Albrecht Bufe; Roger P Lauener; Rudolf Schierl; Harald Renz; Dennis Nowak; Erika von Mutius
Journal:  N Engl J Med       Date:  2002-09-19       Impact factor: 91.245

Review 7.  Inflammatory group 2 innate lymphoid cells.

Authors:  Yuefeng Huang; William E Paul
Journal:  Int Immunol       Date:  2015-08-01       Impact factor: 4.823

Review 8.  Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Authors:  Cezmi A Akdis
Journal:  Nat Rev Immunol       Date:  2021-04-12       Impact factor: 53.106

9.  Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation.

Authors:  Kei E Fujimura; Alexandra R Sitarik; Suzanne Havstad; Din L Lin; Sophia Levan; Douglas Fadrosh; Ariane R Panzer; Brandon LaMere; Elze Rackaityte; Nicholas W Lukacs; Ganesa Wegienka; Homer A Boushey; Dennis R Ownby; Edward M Zoratti; Albert M Levin; Christine C Johnson; Susan V Lynch
Journal:  Nat Med       Date:  2016-09-12       Impact factor: 53.440

10.  Healthy infants harbor intestinal bacteria that protect against food allergy.

Authors:  Taylor Feehley; Catherine H Plunkett; Riyue Bao; Sung Min Choi Hong; Elliot Culleen; Pedro Belda-Ferre; Evelyn Campbell; Rosita Aitoro; Rita Nocerino; Lorella Paparo; Jorge Andrade; Dionysios A Antonopoulos; Roberto Berni Canani; Cathryn R Nagler
Journal:  Nat Med       Date:  2019-01-14       Impact factor: 53.440

View more
  6 in total

1.  Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases.

Authors:  Rohit Gaurav; Jill A Poole
Journal:  J Asthma       Date:  2021-12-27

2.  Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection.

Authors:  Krist Helen Antunes; Gisele Cassão; Leonardo Duarte Santos; Sofia Giacomet Borges; Juliana Poppe; João Budelon Gonçalves; Eduarda da Silva Nunes; Guilherme Fernando Recacho; Vitória Barbosa Sousa; Gabriela Souza Da Silva; Daniel Mansur; Renato T Stein; Christian Pasquali; Ana Paula Duarte De Souza
Journal:  Front Immunol       Date:  2022-05-05       Impact factor: 8.786

Review 3.  Dietary Fibers: Effects, Underlying Mechanisms and Possible Role in Allergic Asthma Management.

Authors:  Roos E M Verstegen; Atanaska I Kostadinova; Zenebech Merenciana; Johan Garssen; Gert Folkerts; Rudi W Hendriks; Linette E M Willemsen
Journal:  Nutrients       Date:  2021-11-19       Impact factor: 5.717

Review 4.  From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine.

Authors:  Laura Maintz; Thomas Bieber; Helen D Simpson; Anne-Laure Demessant-Flavigny
Journal:  J Pers Med       Date:  2022-05-28

Review 5.  Promising Immunomodulatory Effects of Bacterial Lysates in Allergic Diseases.

Authors:  Agnieszka Kaczynska; Martyna Klosinska; Kamil Janeczek; Michał Zarobkiewicz; Andrzej Emeryk
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

6.  Aerosol Inhalation of Heat-Killed Clostridium butyricum CGMCC0313-1 Alleviates Allergic Airway Inflammation in Mice.

Authors:  Laodong Li; Qixiang Sun; Huan Xiao; Qiannan Zhang; Siyue Xu; Lejin Lai; Zhengning Li; Chaoqian Li
Journal:  J Immunol Res       Date:  2022-08-05       Impact factor: 4.493

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.